Surgical Sutures Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Surgical Sutures Pipeline Market Report Overview

Surgical sutures are used to hold tissues together after injury or surgery to enhance the natural healing process. They are commonly used on the skin, internal tissues, organs, and blood vessels. Sutures are available in absorbable and non-absorbable suture types. The surgical sutures pipeline market research report provides comprehensive information about the surgical sutures pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress.

Key Segments ·        Sutures

·        Absorbable Sutures

·        Disposable Automated Suturing Devices

·        Automated Suturing Devices

·        Reusable Automated Suturing Devices

·        Knotless Absorbable Sutures

Key Territories ·        The US

·        Europe

·        Indonesia

·        China

Key Regulatory Paths ·        510(k)

·        CE

·        NMPA

·        PMA

Leading Companies ·        Anastom Surgical

·        Anika Therapeutics Inc

·        Apollo Endosurgery Inc

·        CorMedix Inc

·        Curical Technologies Ltd

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Surgical Sutures Pipeline Market by Segments

Some of the key segments in the surgical sutures pipeline market are sutures, absorbable sutures, disposable automated suturing devices, automated suturing devices, reusable automated suturing devices, and knotless absorbable sutures, among others. As of November 2023, the sutures segment dominated the market with the highest number of pipeline products.

Surgical sutures are used to hold tissues together after injury or surgery to enhance the natural healing process. They are commonly used on the skin, internal tissues, organs, and blood vessels. Sutures are used in all types of surgical procedures and trauma cases. Automated Suturing Devices and Sutures are included under this category.

Surgical Sutures Pipeline Market Analysis by Segments, 2023 (%)

Surgical Sutures Pipeline Market Analysis by Segments, 2023 (%)

Buy the Full Report for More Segment Insights into the Surgical Sutures Pipeline Market
Download a Free Report Sample

Surgical Sutures Pipeline Market Segmentation by Territories

Some of the key territories in the surgical sutures market are the US, Europe, Indonesia, and China. As of November 2023, the US has the highest number of pipeline products.

Surgical Sutures Pipeline Market Analysis by Territories, 2023 (%)

Surgical Sutures Pipeline Market Analysis by Territories, 2023 (%)

Buy the Full Report for More Territory Insights into the Surgical Sutures Pipeline Market

Download a Free Report Sample

Surgical Sutures Pipeline Market Segmentation by Regulatory Paths

Some of the key regulatory paths in the surgical sutures pipeline market are 510(k), CE, NMPA, and PMA. As of November 2023, 510(k) is the most followed pathway for pipeline products in the market.

Surgical Sutures Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Surgical Sutures Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Buy the Full Report for More Regulatory Path Insights into the Surgical Sutures Pipeline Market

Download a Free Report Sample

Surgical Sutures Pipeline Market – Competitive Landscape

Some of the key companies in the surgical sutures pipeline market are Anastom Surgical, Anika Therapeutics Inc., Apollo Endosurgery Inc., Cardiva Medical Inc., and CorMedix Inc. among others.

Cardiva Medical Inc: Cardiva Medical Inc (Cardiva) designs, develops, and commercializes vascular access management products. The major products of the company include VASCADE vascular closure system (VCS) for femoral arterial access site closure post-diagnostic and interventional endovascular procedures VASCADE MVP for Electrophysiology (EP) procedures, Cardiva Catalyst II and Cardiva Catalyst III manual compression assist devices which are designed for heparinized patients.

Surgical Sutures Pipeline Market Analysis by Companies, 2023

Surgical Sutures Pipeline Market Analysis by Companies, 2023

Buy the Full Report for More Company Insights into the Surgical Sutures Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Surgical Sutures Pipeline Market Segments Outlook

  • Sutures
  • Absorbable Sutures
  • Disposable Automated Suturing Devices
  • Automated Suturing Devices
  • Reusable Automated Suturing Devices
  • Knotless Absorbable Sutures

Surgical Sutures Pipeline Market Territories Outlook

  • The US
  • Europe
  • Indonesia
  • China

Surgical Sutures Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • CE
  • NMPA
  • PMA

Scope

This report provides:

  • Extensive coverage of the surgical sutures under development.
  • Details of major pipeline products which include product description, licensing and collaboration details and other developmental activities.
  • Reviews of major players involved in the development of surgical sutures and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Provides key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of surgical sutures under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Anastom Surgical
Anika Therapeutics Inc
Apollo Endosurgery Inc
Biosurfaces Inc
Cardiva Medical Inc
CorMedix Inc
Curical Technologies Ltd
Envision Endoscopy Inc
Ergosuture Corp
Ethicon Endo-Surgery Inc
Ethicon US LLC
Hangzhou Kangji Medical Instrument Co Ltd
Indian Institute of Technology Bombay
Indian Institute of Technology Delhi
Innovation Pharmaceuticals Inc
Johns Hopkins University
Mellon Medical BV
Mesh Suture Inc
MiMedx Group Inc
Nobles Medical Technology, Inc.
NuVascular Technologies Inc
PT Kalbe Farma Tbk
RMIT University
Scarless Laboratories Inc
Silver Bullet Therapeutics, Inc.
Sutrue Ltd
Tepha Inc
TissueGen Inc
Universidade Nova de Lisboa
University of North Carolina at Chapel Hill
University of Wisconsin Madison
VitaThreads, LLC

Table of Contents

1 Table of Contents 3

1.1 List of Tables 6

1.2 List of Figures 9

2 Introduction 10

2.1 Surgical Sutures Overview 10

3 Products under Development 11

3.1 Surgical Sutures – Pipeline Products by Stage of Development 11

3.2 Surgical Sutures – Pipeline Products by Segment 12

3.3 Surgical Sutures – Pipeline Products by Territory 13

3.4 Surgical Sutures – Pipeline Products by Regulatory Path 14

3.5 Surgical Sutures – Pipeline Products by Estimated Approval Date 15

3.6 Surgical Sutures – Ongoing Clinical Trials 16

4 Surgical Sutures – Pipeline Products under Development by Companies 17

4.1 Surgical Sutures Companies – Pipeline Products by Stage of Development 17

4.2 Surgical Sutures – Pipeline Products by Stage of Development 19

5 Surgical Sutures Companies and Product Overview 21

5.1 Anastom Surgical Company Overview 21

5.1.1 Anastom Surgical Pipeline Products & Ongoing Clinical Trials Overview 21

5.2 Anika Therapeutics Inc Company Overview 22

5.2.1 Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 22

5.3 Apollo Endosurgery Inc Company Overview 23

5.3.1 Apollo Endosurgery Inc Pipeline Products & Ongoing Clinical Trials Overview 23

5.4 Biosurfaces Inc Company Overview 26

5.4.1 Biosurfaces Inc Pipeline Products & Ongoing Clinical Trials Overview 26

5.5 Cardiva Medical Inc Company Overview 27

5.5.1 Cardiva Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 27

5.6 CorMedix Inc Company Overview 28

5.6.1 CorMedix Inc Pipeline Products & Ongoing Clinical Trials Overview 28

5.7 Curical Technologies Ltd Company Overview 29

5.7.1 Curical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 29

5.8 Envision Endoscopy Inc Company Overview 30

5.8.1 Envision Endoscopy Inc Pipeline Products & Ongoing Clinical Trials Overview 30

5.9 Ergosuture Corp Company Overview 31

5.9.1 Ergosuture Corp Pipeline Products & Ongoing Clinical Trials Overview 31

5.10 Ethicon Endo-Surgery Inc Company Overview 34

5.10.1 Ethicon Endo-Surgery Inc Pipeline Products & Ongoing Clinical Trials Overview 34

5.11 Ethicon US LLC Company Overview 35

5.11.1 Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview 35

5.12 Hangzhou Kangji Medical Instrument Co Ltd Company Overview 37

5.12.1 Hangzhou Kangji Medical Instrument Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 37

5.13 Indian Institute of Technology Bombay Company Overview 38

5.13.1 Indian Institute of Technology Bombay Pipeline Products & Ongoing Clinical Trials Overview 38

5.14 Indian Institute of Technology Delhi Company Overview 39

5.14.1 Indian Institute of Technology Delhi Pipeline Products & Ongoing Clinical Trials Overview 39

5.15 Innovation Pharmaceuticals Inc Company Overview 40

5.15.1 Innovation Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 40

5.16 Johns Hopkins University Company Overview 41

5.16.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 41

5.17 Mellon Medical BV Company Overview 42

5.17.1 Mellon Medical BV Pipeline Products & Ongoing Clinical Trials Overview 42

5.18 Mesh Suture Inc Company Overview 47

5.18.1 Mesh Suture Inc Pipeline Products & Ongoing Clinical Trials Overview 47

5.19 MiMedx Group Inc Company Overview 53

5.19.1 MiMedx Group Inc Pipeline Products & Ongoing Clinical Trials Overview 53

5.20 Nobles Medical Technology, Inc. Company Overview 54

5.20.1 Nobles Medical Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 54

5.21 NuVascular Technologies Inc Company Overview 57

5.21.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 57

5.22 PT Kalbe Farma Tbk Company Overview 58

5.22.1 PT Kalbe Farma Tbk Pipeline Products & Ongoing Clinical Trials Overview 58

5.23 RMIT University Company Overview 59

5.23.1 RMIT University Pipeline Products & Ongoing Clinical Trials Overview 59

5.24 Scarless Laboratories Inc Company Overview 60

5.24.1 Scarless Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 60

5.25 Silver Bullet Therapeutics, Inc. Company Overview 61

5.25.1 Silver Bullet Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 61

5.26 Sutrue Ltd Company Overview 62

5.26.1 Sutrue Ltd Pipeline Products & Ongoing Clinical Trials Overview 62

5.27 Tepha Inc Company Overview 63

5.27.1 Tepha Inc Pipeline Products & Ongoing Clinical Trials Overview 63

5.28 TissueGen Inc Company Overview 64

5.28.1 TissueGen Inc Pipeline Products & Ongoing Clinical Trials Overview 64

5.29 Universidade Nova de Lisboa Company Overview 65

5.29.1 Universidade Nova de Lisboa Pipeline Products & Ongoing Clinical Trials Overview 65

5.30 University of North Carolina at Chapel Hill Company Overview 66

5.30.1 University of North Carolina at Chapel Hill Pipeline Products & Ongoing Clinical Trials Overview 66

5.31 University of Wisconsin Madison Company Overview 67

5.31.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 67

5.32 VitaThreads, LLC Company Overview 68

5.32.1 VitaThreads, LLC Pipeline Products & Ongoing Clinical Trials Overview 68

6 Surgical Sutures- Recent Developments 69

6.1 Oct 31, 2023: CONMED Corp. to Participate in Fireside Chats at Two Investor Conferences on November 14-15 69

6.2 Oct 26, 2023: Arthrex Obtains Additional 510(K) Clearance For Arthrex FiberTape Cerclage Suture 69

6.3 Oct 26, 2023: Arthrex Receives Additional 510(K) Clearance For TigerTape Cerclage Suture 69

6.4 Oct 16, 2023: MIMEDX to Host Third Quarter 2023 Operating and Financial Results Conference Call on October 30 70

6.5 Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business 70

6.6 Oct 02, 2023: Shandong Haidike Medical Products Obtains 510(k) Clearance for Non Absorbable Surgical Polypropylene Suture 70

6.7 Oct 02, 2023: Advanced Medical Solutions Group Announces Appointment of New Chair 71

6.8 Sep 18, 2023: Shandong Weigao Group Medical Polymer Co. Notice of the Third Extraordinary General Meeting 71

6.9 Sep 14, 2023: Arthrex Receives 510(k) Clearance for Radiopaque FiberTape Cerclage Suture 72

6.10 Sep 12, 2023: Genesis receives approval in China for antibacterial sutures 72

6.11 Sep 08, 2023: Shandong Haidike Medical Products Receives 510(k) Clearance for Non Absorbable Surgical Polyester Suture 73

6.12 Sep 08, 2023: Dominik Arnold to Become New CEO of the COLTENE Group 73

6.13 Sep 06, 2023: KMS Medisurgi Notice of 25Th Annual General Meeting 73

6.14 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair 74

6.15 Aug 22, 2023: Arcuro Medical Receives Additional 510(k) clearance for SuperBall Meniscal Repair System 74

6.16 Aug 17, 2023: Smith & Nephew Receives Additional 510(k) Clearance for ULTRATAPE 74

6.17 Aug 17, 2023: Huaian Seamen Medical Technology Receives 510(k) Clearance for Surgical Suture With Or Without Needle 74

6.18 Aug 12, 2023: Centenial Surgical Suture Re-appoints Ms. Anuradha Kashikar as Executive Director 74

6.19 Aug 10, 2023: Advanced Medical Solutions Group Notice of Interim Results 75

6.20 Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024 75

6.21 Jul 14, 2023: Apollo Endosurgery Receives 510(k) Clearance for OverStitch NXT Endoscopic Suturing System 75

6.22 Jul 14, 2023: TAS Medical Receives 510(k) Clearance for Tissue Approximation System (TAS) 75

6.23 May 30, 2023: KMS Medisurgi announces standalone audited financial results for the year ended 31st March, 2023 75

6.24 May 29, 2023: KMS Medisurgi Announces Proceedings of the Extraordinary General Meeting 76

6.25 May 29, 2023: Weigao Group Medical Polymer announces poll results of annual general meeting held on 29 May 2023 77

6.26 May 27, 2023: Centenial Surgical Suture Announces Standalone Audited Financial Results for the Quarter and Year Ended March 31, 2023 77

6.27 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023 77

6.28 May 09, 2023: Croma-Pharma reports 27% revenue growth in 2022 and targets further revenue growth in 2023 and thereafter 78

6.29 May 03, 2023: KMS Medisurgi Announces Resignation of Rekha Devang Kanakia as Managing Director 78

6.30 May 03, 2023: Kms Medisurgi Announces Resignation of Managing Director, Mrs. Rekha Devang Kanakia 79

6.31 May 02, 2023: PDO Max launches PDO MAX DUO PDO threads: advanced precision for maximum results 80

6.32 May 02, 2023: MIMEDX announces first quarter 2023 operating and financial results 80

6.33 Apr 26, 2023: Merit Medical reports results for first quarter March 31, 2023 82

6.34 Apr 12, 2023: Medtronic has a layoff in California 83

6.35 Apr 06, 2023: Merit Medical Systems to Announce First Quarter 2023 Results on April 26, 2023 83

6.36 Mar 27, 2023: HansBiomed receives 510(k) clearance for MINT Lift ML 84

6.37 Mar 27, 2023: HansBiomed receives 510(k) clearance for MINT Lift Mini 1014 84

6.38 Mar 26, 2023: HansBiomed receives additional 510(k) clearance for Mint 84

6.39 Mar 16, 2023: Kalbe developed surgical sutures, supporting the resilience of the national health industry 84

6.40 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company 85

6.41 Feb 03, 2023: Merit Medical Systems to Announce Fourth Quarter and Year End 2022 Results and Issue Fiscal Year 2023 Guidance on February 22, 2023 86

6.42 Feb 01, 2023: Smart stitches to reduce infection, simplify post op monitoring 86

6.43 Jan 23, 2023: Able Medical Devices introduces looped wire sutures 87

6.44 Jan 10, 2023: Lydus Medical announces FDA clearance of Vesseal, The microvascular anastomosis aid device for small arteries 88

6.45 Jan 09, 2023: MIMEDX Confirms Fourth Quarter and Full Year 2022 Net Sales Expectations, Comments on Evolving Medicare Reimbursement Landscape and Provides Corporate Updates 88

6.46 Jan 03, 2023: MIMEDX Appoints Ricci S. Whitlow as Chief Operating Officer 90

6.47 Dec 20, 2022: Lydus Medical receives 510(k) clearance for Vesseal 91

6.48 Dec 13, 2022: Apollo Endosurgery announces two important milestones in the advancement of endoscopic procedures for patients living with obesity 91

6.49 Dec 08, 2022: MIMEDX Announces Wound & Surgical Product Pipeline Expansion via In-Licensing and Distribution Agreement with Turn Therapeutics 92

7 Appendix 93

7.1 Methodology 93

7.2 About GlobalData 96

7.3 Contact Us 96

7.4 Disclaimer 96

Table

Surgical Sutures – Pipeline Products by Stage of Development 11

Surgical Sutures – Pipeline Products by Segment 12

Surgical Sutures – Pipeline Products by Territory 13

Surgical Sutures – Pipeline Products by Regulatory Path 14

Surgical Sutures – Pipeline Products by Estimated Approval Date 15

Surgical Sutures – Ongoing Clinical Trials 16

Surgical Sutures Companies – Pipeline Products by Stage of Development 17

Surgical Sutures – Pipeline Products by Stage of Development 19

Anastom Surgical Pipeline Products & Ongoing Clinical Trials Overview 21

Gastrolink – Product Status 21

Gastrolink – Product Description 21

Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 22

Tissue Repair Suture – Product Status 22

Tissue Repair Suture – Product Description 22

Apollo Endosurgery Inc Pipeline Products & Ongoing Clinical Trials Overview 23

X-Tack Endoscopic HeliX Tacking System – Product Status 23

X-Tack Endoscopic HeliX Tacking System – Product Description 23

Apollo Endosurgery Inc – Ongoing Clinical Trials Overview 24

X-Tack Endoscopic HeliX Tacking System – Comparison of the Performance of Standard Through the Scope (TTS) Clip Versus X-tack Suture for Closure of Gastrointestinal Defects 25

Biosurfaces Inc Pipeline Products & Ongoing Clinical Trials Overview 26

Drug-Eluting Sutures – Product Status 26

Drug-Eluting Sutures – Product Description 26

Cardiva Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 27

Dual-Close – Product Status 27

Dual-Close – Product Description 27

CorMedix Inc Pipeline Products & Ongoing Clinical Trials Overview 28

CMDX-006 – Synthetic Suture – Product Status 28

CMDX-006 – Synthetic Suture – Product Description 28

Curical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 29

Absorbable Multifilament Suture – Product Status 29

Absorbable Multifilament Suture – Product Description 29

Envision Endoscopy Inc Pipeline Products & Ongoing Clinical Trials Overview 30

Image-Guided Suturing Device – Product Status 30

Image-Guided Suturing Device – Product Description 30

Ergosuture Corp Pipeline Products & Ongoing Clinical Trials Overview 31

Drive’N Rock – Product Status 31

Drive’N Rock – Product Description 31

Drive’N Roll – Disposable – Product Status 32

Drive’N Roll – Disposable – Product Description 32

Drive’N Roll – Reusable – Product Status 32

Drive’N Roll – Reusable – Product Description 33

Ethicon Endo-Surgery Inc Pipeline Products & Ongoing Clinical Trials Overview 34

PROXISURE Next Gen – Product Status 34

PROXISURE Next Gen – Product Description 34

Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview 35

Additional PLUS Barbed Suture – Product Status 35

Additional PLUS Barbed Suture – Product Description 35

VICRYL (Polydactin 910) – Next Gen – Product Status 36

VICRYL (Polydactin 910) – Next Gen – Product Description 36

Hangzhou Kangji Medical Instrument Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 37

Absorbable Knotless Suture – Product Status 37

Absorbable Knotless Suture – Product Description 37

Indian Institute of Technology Bombay Pipeline Products & Ongoing Clinical Trials Overview 38

Suturing Device – Product Status 38

Suturing Device – Product Description 38

Indian Institute of Technology Delhi Pipeline Products & Ongoing Clinical Trials Overview 39

Antimicrobial Sutures – Product Status 39

Antimicrobial Sutures – Product Description 39

Innovation Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 40

Antimicrobial Suture – Product Status 40

Antimicrobial Suture – Product Description 40

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 41

Drug-Loaded Microfiber Suture – Product Status 41

Drug-Loaded Microfiber Suture – Product Description 41

Mellon Medical BV Pipeline Products & Ongoing Clinical Trials Overview 42

Switch – Product Status 42

Switch – Product Description 42

Switch – 10cm Model – Product Status 43

Switch – 10cm Model – Product Description 43

Switch – 11cm Model – Product Status 43

Switch – 11cm Model – Product Description 44

Switch – Electrical Model With Exchangeable Jaws – Product Status 44

Switch – Electrical Model With Exchangeable Jaws – Product Description 44

Switch – Laparoscopic Model – Product Status 44

Switch – Laparoscopic Model – Product Description 45

Switch – Micro Surgery Model – Product Status 45

Switch – Micro Surgery Model – Product Description 45

Switch – Robotic Version – Product Status 46

Switch – Robotic Version – Product Description 46

Mesh Suture Inc Pipeline Products & Ongoing Clinical Trials Overview 47

Aeramesh – Product Status 47

Aeramesh – Product Description 47

Duramesh Absorbable Suture – Product Status 48

Duramesh Absorbable Suture – Product Description 48

Ligamesh – Product Status 48

Ligamesh – Product Description 49

Tempormesh – Product Status 49

Tempormesh – Product Description 49

Tempramesh – Product Status 49

Tempramesh – Product Description 50

Tetracord – Product Status 50

Tetracord – Product Description 50

Theramesh – Product Status 50

Theramesh – Product Description 51

Vapourmesh – Product Status 51

Vapourmesh – Product Description 51

Zorbamesh – Product Status 52

Zorbamesh – Product Description 52

MiMedx Group Inc Pipeline Products & Ongoing Clinical Trials Overview 53

CollaFix Collagen Fiber Suture – Product Status 53

CollaFix Collagen Fiber Suture – Product Description 53

Nobles Medical Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 54

NobleStitch QP – Product Status 54

NobleStitch QP – Product Description 54

SuperStitch ASD II – Product Status 55

SuperStitch ASD II – Product Description 55

SuperStitch II – Product Status 55

SuperStitch II – Product Description 56

NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 57

NuSpun Arteriovenous Suture – Product Status 57

NuSpun Arteriovenous Suture – Product Description 57

PT Kalbe Farma Tbk Pipeline Products & Ongoing Clinical Trials Overview 58

Surgical Suture – Product Status 58

Surgical Suture – Product Description 58

RMIT University Pipeline Products & Ongoing Clinical Trials Overview 59

Smart Surgical Suture – Product Status 59

Smart Surgical Suture – Product Description 59

Scarless Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 60

Peptide-Coated Suture – Product Status 60

Peptide-Coated Suture – Product Description 60

Silver Bullet Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 61

Antimicrobial Suture – Product Status 61

Antimicrobial Suture – Product Description 61

Sutrue Ltd Pipeline Products & Ongoing Clinical Trials Overview 62

Robotic/Endoscopic Suturing Device – Product Status 62

Robotic/Endoscopic Suturing Device – Product Description 62

Tepha Inc Pipeline Products & Ongoing Clinical Trials Overview 63

TephaFLEX Absorbable Multifilament Fiber – Product Status 63

TephaFLEX Absorbable Multifilament Fiber – Product Description 63

TissueGen Inc Pipeline Products & Ongoing Clinical Trials Overview 64

ELUTE Fiber – Smart Suture – Product Status 64

ELUTE Fiber – Smart Suture – Product Description 64

Universidade Nova de Lisboa Pipeline Products & Ongoing Clinical Trials Overview 65

Nanosuture – Product Status 65

Nanosuture – Product Description 65

University of North Carolina at Chapel Hill Pipeline Products & Ongoing Clinical Trials Overview 66

Angiogenic Suture – Product Status 66

Angiogenic Suture – Product Description 66

University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 67

Biologically Active Suture – Product Status 67

Biologically Active Suture – Product Description 67

VitaThreads, LLC Pipeline Products & Ongoing Clinical Trials Overview 68

VitaSuture Wound Management System – Product Status 68

VitaSuture Wound Management System – Product Description 68

Glossary 95

Figures

Surgical Sutures – Pipeline Products by Stage of Development 10_x000D_

Surgical Sutures – Pipeline Products by Segment 11_x000D_

Surgical Sutures – Pipeline Products by Territory 12_x000D_

Surgical Sutures – Pipeline Products by Regulatory Path 13_x000D_

Surgical Sutures – Pipeline Products by Estimated Approval Date 14_x000D_

Surgical Sutures – Ongoing Clinical Trials 15_x000D_

Frequently asked questions

Surgical Sutures Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Surgical Sutures Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Surgical Sutures Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Surgical Sutures Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.